Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome
- PMID: 9843997
- PMCID: PMC24557
- DOI: 10.1073/pnas.95.25.14956
Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome
Abstract
Our preliminary family studies have suggested that some female first-degree relatives of women with polycystic ovary syndrome (PCOS) have hyperandrogenemia per se. It was our hypothesis that this may be a genetic trait and thus could represent a phenotype suitable for linkage analysis. To investigate this hypothesis, we examined 115 sisters of 80 probands with PCOS from unrelated families. PCOS was diagnosed by the combination of elevated serum androgen levels and </=6 menses per year with the exclusion of secondary causes. The sisters were compared with 70 healthy age- and weight-comparable control women with regular menses, no clinical evidence of hyperandrogenemia, and normal glucose tolerance. Twenty-two percent of the sisters fulfilled diagnostic criteria for PCOS. In addition, 24% of the sisters had hyperandrogenemia and regular menstrual cycles. Circulating testosterone (T) and nonsex hormone-binding globulin-bound testosterone (uT) levels in both of these groups of sisters were significantly increased compared with unaffected sisters and control women (P < 0.0001 for both T and uT). Probands, sisters with PCOS, and hyperandrogenemic sisters had elevated serum luteinizing hormone levels compared with control women. We conclude that there is familial aggregation of hyperandrogenemia (with or without oligomenorrhea) in PCOS kindreds. In affected sisters, only one-half have oligomenorrhea and hyperandrogenemia characteristic of PCOS, whereas the remaining one-half have hyperandrogenemia per se. This familial aggregation of hyperandrogenemia in PCOS kindreds suggests that it is a genetic trait. We propose that hyperandrogenemia be used to assign affected status in linkage studies designed to identify PCOS genes.
Figures
![Figure 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/24557/bin/pq2383190001.gif)
![Figure 2](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/24557/bin/pq2383190002.gif)
![Figure 3](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/24557/bin/pq2383190003.gif)
Similar articles
-
Some new thoughts on the pathophysiology and genetics of polycystic ovary syndrome.Ann N Y Acad Sci. 2003 Nov;997:42-8. doi: 10.1196/annals.1290.005. Ann N Y Acad Sci. 2003. PMID: 14644808 Review.
-
Glucose intolerance, insulin resistance, and hyperandrogenemia in first degree relatives of women with polycystic ovary syndrome.J Clin Endocrinol Metab. 2003 May;88(5):2031-6. doi: 10.1210/jc.2002-021499. J Clin Endocrinol Metab. 2003. PMID: 12727950
-
Insulin resistance in the sisters of women with polycystic ovary syndrome: association with hyperandrogenemia rather than menstrual irregularity.J Clin Endocrinol Metab. 2002 May;87(5):2128-33. doi: 10.1210/jcem.87.5.8513. J Clin Endocrinol Metab. 2002. PMID: 11994352 Free PMC article.
-
Polycystic ovaries are inherited as an autosomal dominant trait: analysis of 29 polycystic ovary syndrome and 10 control families.J Clin Endocrinol Metab. 1999 Jan;84(1):38-43. doi: 10.1210/jcem.84.1.5382. J Clin Endocrinol Metab. 1999. PMID: 9920059
-
Phenotype and genotype in polycystic ovary syndrome.Recent Prog Horm Res. 1998;53:217-56. Recent Prog Horm Res. 1998. PMID: 9769710 Review.
Cited by
-
DENND1A desensitizes granulosa cells to FSH by arresting intracellular FSHR transportation.Sci China Life Sci. 2024 Apr 23. doi: 10.1007/s11427-023-2438-4. Online ahead of print. Sci China Life Sci. 2024. PMID: 38709439
-
Polycystic ovary syndrome.Nat Rev Dis Primers. 2024 Apr 18;10(1):27. doi: 10.1038/s41572-024-00511-3. Nat Rev Dis Primers. 2024. PMID: 38637590 Review.
-
Ovarian ferroptosis induced by androgen is involved in pathogenesis of PCOS.Hum Reprod Open. 2024 Feb 28;2024(2):hoae013. doi: 10.1093/hropen/hoae013. eCollection 2024. Hum Reprod Open. 2024. PMID: 38550897 Free PMC article.
-
Effect of Berberine Phytosome on reproductive, dermatologic, and metabolic characteristics in women with polycystic ovary syndrome: a controlled, randomized, multi-centric, open-label clinical trial.Front Pharmacol. 2023 Nov 21;14:1269605. doi: 10.3389/fphar.2023.1269605. eCollection 2023. Front Pharmacol. 2023. PMID: 38074133 Free PMC article.
-
Effect of Dietary Regimen on the Development of Polycystic Ovary Syndrome: A Narrative Review.Cureus. 2023 Oct 24;15(10):e47569. doi: 10.7759/cureus.47569. eCollection 2023 Oct. Cureus. 2023. PMID: 37881324 Free PMC article. Review.
References
-
- Legro R S, Spielman R, Urbanek M, Driscoll D, Strauss J S, Dunaif A. Recent Prog Horm Res. 1998;53:217–256. - PubMed
-
- Franks S, Gharani N, Waterworth D, Batty S, White D, Williamson R, McCarthy M. Hum Reprod. 1997;12:2641–2648. - PubMed
-
- Ferriman D, Purdie A W. Clin Endocrinol (Oxford) 1979;11:291–300. - PubMed
-
- Lunde O, Magnus P, Sandvik L, Hoglo S. Gynecol Obstet Invest. 1989;28:23–30. - PubMed
-
- Lander E S, Schork N J. Science. 1994;265:2037–2048. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical